A detailed history of Barclays PLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Barclays PLC holds 219,331 shares of AUPH stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
219,331
Previous 76,259 187.61%
Holding current value
$1.78 Million
Previous $435,000 269.43%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$5.32 - $7.33 $761,143 - $1.05 Million
143,072 Added 187.61%
219,331 $1.61 Million
Q2 2024

Aug 14, 2024

SELL
$4.81 - $5.78 $463,996 - $557,567
-96,465 Reduced 55.85%
76,259 $435,000
Q1 2024

May 15, 2024

SELL
$4.93 - $9.31 $225,414 - $425,681
-45,723 Reduced 20.93%
172,724 $865,000
Q4 2023

Feb 15, 2024

BUY
$7.13 - $9.49 $646,826 - $860,923
90,719 Added 71.03%
218,447 $1.96 Million
Q3 2023

Nov 07, 2023

BUY
$7.77 - $12.27 $602,905 - $952,078
77,594 Added 154.77%
127,728 $992,000
Q2 2023

Aug 03, 2023

SELL
$8.96 - $11.69 $159,658 - $208,304
-17,819 Reduced 26.22%
50,134 $485,000
Q1 2023

May 04, 2023

BUY
$5.94 - $11.27 $19,186 - $36,402
3,230 Added 4.99%
67,953 $745,000
Q4 2022

Feb 13, 2023

SELL
$4.11 - $8.14 $2.43 Million - $4.82 Million
-592,079 Reduced 90.15%
64,723 $279,000
Q3 2022

Nov 03, 2022

SELL
$6.66 - $12.39 $2.56 Million - $4.76 Million
-384,252 Reduced 36.91%
656,802 $4.94 Million
Q2 2022

Aug 12, 2022

BUY
$8.95 - $12.8 $5.35 Million - $7.64 Million
597,256 Added 134.58%
1,041,054 $10.5 Million
Q1 2022

May 16, 2022

SELL
$10.05 - $22.48 $908,610 - $2.03 Million
-90,409 Reduced 16.92%
443,798 $5.49 Million
Q4 2021

Feb 14, 2022

SELL
$17.78 - $33.08 $1.08 Million - $2 Million
-60,599 Reduced 10.19%
534,207 $12.2 Million
Q3 2021

Nov 09, 2021

BUY
$10.93 - $23.55 $4.42 Million - $9.51 Million
403,950 Added 211.65%
594,806 $13.2 Million
Q2 2021

Aug 13, 2021

SELL
$10.0 - $14.52 $2.24 Million - $3.26 Million
-224,404 Reduced 54.04%
190,856 $2.47 Million
Q1 2021

May 13, 2021

BUY
$12.3 - $18.73 $3.15 Million - $4.8 Million
256,236 Added 161.13%
415,260 $5.39 Million
Q4 2020

Feb 11, 2021

SELL
$12.94 - $16.05 $815,220 - $1.01 Million
-63,000 Reduced 28.38%
159,024 $2.2 Million
Q3 2020

Nov 12, 2020

BUY
$13.19 - $16.66 $1.9 Million - $2.4 Million
144,338 Added 185.8%
222,024 $3.27 Million
Q1 2020

May 13, 2020

SELL
$11.34 - $21.46 $302,653 - $572,745
-26,689 Reduced 25.57%
77,686 $1.13 Million
Q4 2019

Feb 10, 2020

BUY
$3.88 - $21.42 $132,366 - $730,743
34,115 Added 48.56%
104,375 $2.12 Million
Q3 2019

Nov 14, 2019

BUY
$5.34 - $6.59 $371,626 - $458,617
69,593 Added 10433.73%
70,260 $376,000
Q2 2019

Aug 14, 2019

SELL
$6.05 - $6.75 $1,954 - $2,180
-323 Reduced 32.63%
667 $4,000
Q1 2019

May 15, 2019

BUY
$6.06 - $7.64 $5,817 - $7,334
960 Added 3200.0%
990 $6,000
Q2 2018

Aug 14, 2018

SELL
$5.06 - $6.36 $5,009 - $6,296
-990 Reduced 97.06%
30 $0
Q1 2018

May 15, 2018

BUY
$4.85 - $5.99 $4,947 - $6,109
1,020 New
1,020 $5,000
Q4 2017

Feb 14, 2018

SELL
$4.53 - $7.09 $86,523 - $135,419
-19,100 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$5.71 - $6.9 $109,061 - $131,790
19,100
19,100 $120,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.15B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.